Selank

N-[(3S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]pyrrolidin-2-yl]formyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1H-imidazole-4-carboxamide

Selank is a synthetic anxiolytic peptide that selectively modulates GABA and serotonin neurotransmitter systems while enhancing BDNF expression. It provides anxiolytic effects without sedation, making it ideal for cognitive enhancement and stress management applications.

Clinical Safety Profile

Reported Side Effects

Mild nasal irritation (uncommon)

Occasional nasal dryness

Rare paradoxical anxiety in sensitive individuals

Minor nasal congestion with extended use

Side Effect Management (Clinical Trial Data)

Side Effect Management Strategies

Nausea: Take with food, smaller meals, ginger supplements

Vomiting: Slower dose escalation, anti-emetics if severe

Diarrhea: Adequate hydration, probiotics, bland diet

Constipation: Increase fiber intake, adequate fluids, light exercise

Clinical Safety Metrics

Variable

Overall Safety Rating

Variable

Discontinuation Rate

Research

Approved Status

CONTRAINDICATIONS

• Known hypersensitivity to tuftsin-based compounds

• Severe nasal inflammation or infection

• Active respiratory tract infections

• Pregnancy and breastfeeding (insufficient data)

Medical Disclaimer

This information is for educational purposes only and is not intended as medical advice. Selank is a research compound and should only be used under qualified medical supervision. Consult with a healthcare provider familiar with peptide therapies before considering use. Individual results may vary significantly.

Peptide Database